Cure Parkinson’s and Alzheimer’s Research UK announce a partnership
Cure Parkinson’s and Alzheimer’s Research UK are working on an initiative that could pave the way for innovative neurodegenerative treatments. There is a growing recognition that tackling neurodegenerative diseases could benefit from a collaborative, cross-disease approach. We are recognising the overlap in underlying biological...
Learn more
Helen Matthews takes the helm as new CEO of Cure Parkinson’s
10 August 2023 We are delighted to announce that Helen Matthews will be taking over as CEO of Cure Parkinson’s later this summer. As our current Deputy CEO and former COO, Helen has been a driving force behind the charity since it was formed over…
Fundraiser of the Year 2022
11 April 2023 We were delighted to announce the winner of our 2022 Fundraiser of the Year award as the remarkable Simon Cooper. Simon was instrumental in nominating Lloyd’s syndicate AEGIS London as lead sponsor of Cure Parkinson’s Coast-to-Coast-to-Cure cycle challenge in 2019, and in…
European Software Industry helps fund research to cure Parkinson’s
Cure Parkinson’s is delighted to announce that it has been chosen as the official charity partner to Boardwave supporting Parkinson’s research.
Cough medicine offers hope of new treatment to slow the progression of Parkinson’s disease
10 January 2023 Following promising results reported at Phase 2 in 2020, a large-scale Phase 3 clinical trial of ambroxol, a drug currently in use to treat respiratory conditions, will start in early 2023. The ASPro-PD trial is a world-first Phase 3 trial aimed at…
Cure Parkinson’s announces new role: Head of Pipeline Research
13 October 2022 Cure Parkinson’s is delighted to announce that Dr Leah Mursaleen has been appointed to the newly created role, Head of Pipeline Research. The purpose of this role is to speed up and drive forward early-stage research to ensure that novel treatments for…